HomeRVU • WSE
add
Ryvu Therapeutics SA
Previous close
zł 23.00
Day range
zł 22.00 - zł 22.65
Year range
zł 20.50 - zł 36.00
Market cap
519.05M PLN
Avg Volume
30.53K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 25.78M | -9.50% |
Operating expense | 38.50M | -39.83% |
Net income | -17.59M | 49.82% |
Net profit margin | -68.22 | 44.55% |
Earnings per share | — | — |
EBITDA | -15.15M | 61.26% |
Effective tax rate | -0.41% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 107.68M | -52.34% |
Total assets | 224.44M | -40.75% |
Total liabilities | 170.60M | -24.67% |
Total equity | 53.83M | — |
Shares outstanding | 23.12M | — |
Price to book | 9.87 | — |
Return on assets | -17.50% | — |
Return on capital | -26.56% | — |
Cash Flow
Net change in cash
| (PLN) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -17.59M | 49.82% |
Cash from operations | -28.09M | -0.55% |
Cash from investing | -1.01M | -111.02% |
Cash from financing | -268.00K | -112.38% |
Net change in cash | -29.52M | -80.04% |
Free cash flow | -29.24M | -441.52% |
About
Founded
2007
Website
Employees
228
